The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer

Abstract

While it is clear that CTC numbers and gene expression were prognostic for PCa post-docetaxel treatment, and CTC subtype analysis may have additional value, their potential predictive value for docetaxel chemotherapy response needs to be further investigated in large patient cohorts.